Global Payer Evidence Generation Director (Denmark, Søborg)

Jobbeskrivelse

Placering
Søborg, Denmark

Jobkategori
Market Access

Are you ready to drive the Payer Evidence Generation (PEG) strategy for Novo Nordisk Global Rare Disease? Do you have the expertise to develop evidence generation plans and support market access for our pipeline products? If you are passionate about driving value proposition and supporting payer dialogues, then this role might be perfect for you. Read on and apply today for a life-changing career.

The position
As a Global Payer Evidence Director in the Rare Blood Disorders team, you represent a compelling opportunity within the pharmaceutical industry. As a leader in healthcare, Novo Nordisk seeks individuals who are dedicated to influencing and shaping payer evidence strategies on a global scale. This pivotal role offers the chance to contribute to the company's mission of providing valuable evidence to payers, thereby ensuring access to innovative healthcare solutions worldwide. As a Global PEG Director, you will:

• Set the Payer Evidence Generation (PEG) strategy and develop evidence generation plans to support market access for pipeline products and in-line brands in the Rare Blood Disorders TAs.
• Identify evidence gaps and design PEG projects to mitigate gaps and substantiate the product value proposition.
• Drive activities such as payer relevant endpoints in clinical trials, real-world evidence programs, patient costed pathways, epidemiology studies, and more.
• Lead descriptive and statistical analysis from secondary data sources.
• Manage ad hoc evidence requests from affiliates and support payer dialogues.
• Lead internal and external training on Payer Evidence Generation.
• Establish and maintain a network of stakeholders with influence on payer expectations and access needs.

Qualifications
To be our new Global PEG Director, we are looking for a candidate with the following qualifications:

• Minimum of six years of experience as PEG management (preferably) and/or HEOR and/or payer value communication, within the pharmaceutical industry or consultancy for the pharmaceutical industry.
• Proven track record of impactful scientific publications, particularly peer-reviewed publications, is advantageous.
• University master’s degree in a relevant field such as health economics, outcomes research, epidemiology, or statistics/biostatistics.
• Fluent in written and spoken English with strong project and stakeholder management skills.
• Demonstrated business acumen, strategic thinking, and a positive, "Can do" approach.

About the department
In Novo Nordisk Rare Disease, we are responsible for the development, manufacturing, market access and distribution of high-quality therapeutics for people living with rare diseases like hemophilia or hormonal deficiencies. In Global Rare Disease Access and Pricing, we ensure that there is access to our rare disease products for the people around the world who need it.
The department is an expanding, international, high performing team of dedicated professionals situated in Søborg, Denmark. Optimising market access, we ensure the continued success of the Novo Nordisk Rare Disease Portfolio when we develop and execute strong, evidence-based global access strategies. In close collaboration with key internal stakeholders, Global Rare Disease Access and Pricing establishes these strategies and key support tactics in the areas of pricing, reimbursement, health economics & outcomes research, value communication, and subsequently supports the implementation regionally and locally.

Working at Novo Nordisk
We don’t wait for a change. We drive it.
We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.

Contact
For further information, please contact Tal Waner, Senior Global Market Access Director, at [email protected]

Deadline
7 July 2024
We will screen applications continuously, so don’t hesitate to submit it as soon as possible.
You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.